Washburn Theodore James Jr.'s Form 4 filing
Agios Pharmaceuticals, Inc. (AGIO) · filed Sep 9, 2025
- Accession no.
- 0001439222-25-000102
- Filed
- Sep 9, 2025
- Trade date
- Sep 5, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $315.1K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Washburn Theodore James Jr.CIK 0001874199 | Officer (Principal Accounting Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 5, 2025 | Common stock | SSaleDisposed | −8,546 | $36.87 | −$315,091.02 | 868 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.